about
Obesity-Related Chronic Kidney Disease-The Role of Lipid MetabolismRole of the energy sensor AMP-activated protein kinase in renal physiology and diseaseThe outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice.Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation.Abnormal Processing of Autophagosomes in Transformed B Lymphocytes from SCARB2-Deficient Subjects.AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1.Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.Activation of AMPK reduces the co-transporter activity of NKCC1.Microvascular dilatation after haemodialysis is determined by the volume of fluid removed and fall in mean arterial pressure.Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality.Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.Limited capacity of proximal tubular proteolysis in mice with proteinuria.Acute renal failure following ingestion of wild mushrooms.AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients.Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177.Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK.Impact of anaesthesia on outcomes after radiocephalic arteriovenous fistula creation.The Thiazide-Sensitive Co-Transporter Promotes the Development of Sodium Retention in Mice with Diet-Induced Obesity.Balancing the energy equation for healthy kidneys.Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsiaPhosphorylation of neuronal and endothelial nitric oxide synthase in the kidney with high and low salt dietsRapidly progressive glomerulonephritis complicating primary AL amyloidosis and multiple myelomaPerirenal lymphatic filariasis presenting as chyluria during pregnancyThe CARI guidelines. Natural history and progression of atherosclerotic renal vascular stenosisThe CARI guidelines. Endovascular treatmentThe CARI guidelines. Screening tests for diagnosis of renal artery stenosisThe CARI guidelines. Inhibition of the renin-angiotensin systemClinical outcomes after arteriovenous fistula creation in chronic kidney diseaseThe importance of residual kidney function in haemodialysis patientsBaseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): the Australian cohort in a global aHUS registry
P50
Q26774143-4E253E84-1251-43CE-9623-876C32E52C72Q33840570-AFD81C55-2E40-4A22-8919-F41DB5FDE4B0Q34130765-41784685-579F-410D-A9BC-A89151BFB299Q36535244-FE106D36-D857-4CAB-9E27-9D84032C6E1CQ36602948-8B7F8F1C-6648-4B69-A478-505E87FDB2CBQ37142499-3123C9EF-59B0-4D8A-B132-DC69DFB128B5Q38301888-11C93E62-E989-4EA6-BBD3-23AF145D7603Q39007844-56B52AD7-692B-4DCF-BE5D-43896ADAB121Q40071141-65503B51-86C8-4D7F-AA23-C7014F94A078Q40493855-B0AF4872-B9A4-4873-94A6-056580C11A1EQ41191985-250C54D6-D7E4-410D-9A17-A9010B274AD6Q42519740-C49DDB86-EF25-4319-A97A-39D8639F2E65Q43958211-3EBFEB5C-FFDB-4C5F-9403-DC3102058F86Q45367463-E1AEA6CA-B4C9-4A90-892C-05A00D5463CBQ46508470-26F9542D-C5CD-4CD0-BD43-61328F238937Q46810678-50BA1ADF-3F5A-4901-92C2-81BA7608B020Q47709670-0093F86F-379D-4E3F-BBD7-8DD100F6ADC8Q47931987-2DF3B7A4-7BE3-43D5-93B0-67D8F917EE26Q47944758-B2FED1BA-A7BB-4D49-B1D3-0D0BE27A027AQ48108330-AAE041EF-FA54-4512-8785-3A500086A41DQ64089847-08B39669-1D9A-4B57-80DF-0044EDFA447AQ81392174-0A6ED5BC-5334-41BF-9100-5E025B5F5C38Q82369444-5B66310F-5F47-45E6-B4E4-4931785D017FQ83948560-8BF644D7-E8A6-4CCB-A71B-E2C840054CD7Q84508285-931FB55C-44C6-4FB4-B6EA-442F5A258EC1Q84508289-C682EE2D-6D3F-44CD-B6B3-29D6FA010BFBQ84508292-18C1020E-48CD-4E4C-9846-D5928BF804DDQ84508295-95897CC9-7D07-4015-8C2E-0274CC4C6DCBQ87773785-E166E371-802F-4A6D-80D0-9728CA75D135Q89154725-0C7583E1-F5FF-4514-BA52-AD9FCB6CE623Q94600617-04D1DB9C-31DF-493F-B3F5-F7E901D5BFD1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Mount
@ast
Peter Mount
@en
Peter Mount
@es
Peter Mount
@nl
Peter Mount
@sl
type
label
Peter Mount
@ast
Peter Mount
@en
Peter Mount
@es
Peter Mount
@nl
Peter Mount
@sl
prefLabel
Peter Mount
@ast
Peter Mount
@en
Peter Mount
@es
Peter Mount
@nl
Peter Mount
@sl
P106
P108
P21
P31
P496
0000-0001-7637-3661